SCNI · Scinai Immunotherapeutics Ltd. · Insider Trading

$0.68 -0.07 (-9.16%) At close · Oct 20

Market Cap

$1.01M

1.35M

Volume · Oct 20 129.55K Avg daily vol (42 sessions) 3.24M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-06-16	GERMAIN MARK	Director	Award↑ Filing footnotes — Ordinary Shares (Direct) The Ordinary Shares are no par value per share, and are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares. Includes 120,000,000 Ordinary Shares represented by restricted share units granted on June 16, 2026, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates.	Ordinary Shares	120,000,000	—	—	12,000,000
2026-06-16	Reichman Amir	Director, Chief Executive Officer	Award↑ Filing footnotes — Ordinary Shares (Direct) The Ordinary Shares are no par value per share, and are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares. Includes 400,000,000 Ordinary Shares represented by restricted share units ("RSUs") granted on June 16, 2026, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates. Includes 71,637,600 Ordinary Shares represented by RSUs granted on January 25, 2024, of which 25% vested on the six-month anniversary thereof, 8.33% vested on the one-year anniversary thereof, and 66.66% vest in two equal annual installments thereafter, subject to the Reporting Person's continued service through such dates. Each RSU represents a contingent right to receive one Ordinary Share upon vesting. Includes 240,000,000 Ordinary Shares represented by RSUs granted on December 22, 2025, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates.	Ordinary Shares	400,000,000	—	—	71,163,760

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–2 of 2 transactions

Key facts CIK 1611747 CUSIP 09073Q402 Visit website Investor relations